Clinical Trial

PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer

Name: PSMA-PET Directed Radiation Therapy for High-Risk Prostate Cancer — clinical trial record (NCT07291557)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

In this study, prostate cancer patients whose cancer has not spread to the lymph nodes will receive radiation therapy targeted to the prostate and nearby tissues with or without whole pelvis radiation therapy. PSMA imaging will be used to visualize prostate cancer prior to starting the trial.

Trial Details

NCT Number	NCT07291557
Lead Sponsor	AHS Cancer Control Alberta Collaborators: Cross Cancer Institute
Conditions	Prostate Cancer
Enrollment	250 participants
Start Date	2026-05
Primary Completion	2031-05 (estimated)
Study Completion	2036-05 (estimated)
Updated on ClinicalTrials.gov	2025-12-18